These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4612204)

  • 1. [Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
    Nakano Y; Fukui I; Niiho S; Kuki H; Takahata J
    Nihon Rinsho; 1974 Jul; 32(7):2526-51. PubMed ID: 4612204
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term administration of 3,5-diodo-4(3'-iodo4'-acetoxyphenoxy) benzoic acid (acetiromate) in hyperlipidemic patients.
    Kumaoka S
    Endocrinol Jpn; 1974 Aug; 21(4):355-60. PubMed ID: 4142437
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
    Schäfer B; Kluthe R
    Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 6. The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
    Lam HC; Li SH; Wang JT; Tang KT; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Nov; 40(5):463-70. PubMed ID: 3332236
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of 100 cases of essential atherogenic hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1975 Nov; 51(9):467-71. PubMed ID: 173023
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
    Suzuki K; Aono S; Nakatani H
    Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of several hypolipidemic agents related to clofibrate.
    Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
    Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 12. [Letter: Etofibrate and clofibrate in double blind study].
    Knipping W; Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1976 Apr; 101(16):627-9. PubMed ID: 770108
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of pantethine on different models of experimental hyperlipidemia in rodents: a comparison with clofibrate.
    Farina R; Lovati MR; Raucci G; Sirtori CR
    Pharmacol Res Commun; 1982 Jun; 14(6):499-510. PubMed ID: 7122675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of beta-benzalbutyramide and clofibrate in the short-term treatment of hyperlipidemic patients].
    Marini U; Bargiggia A; Riboli P
    Farmaco Prat; 1981 Dec; 36(12):532-41. PubMed ID: 7319020
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the therapeutic effect of clofibrate in discontinuous administration].
    Cottet J; Cristol R; Loeper J; Debray J
    Therapie; 1974; 29(5):675-9. PubMed ID: 4618386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and experimental study of Typha angustata on hyperlipoidemia].
    Zhang BZ
    Zhong Xi Yi Jie He Za Zhi; 1985 Mar; 5(3):141-4, 130. PubMed ID: 3157493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.